IPHA

Innate Pharma
IPHA

8 hedge funds and large institutions have $545K invested in Innate Pharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18.6K

Top Sellers

1
-$20.4K
2
-$5.17K
3
-$1.29K
4
Barclays
Barclays
United Kingdom
-$342
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$199K
2
$177K
3
$99.7K
4
$48.7K
5
$19.3K
6
$1K
7
$469
8
$458